Paxil Birth Defect Lawsuit Settlements Reach $1 Billion
GlaxoSmithKline, the manufacturer of Paxil, has reportedly agreed to settle some 800 Paxil birth defect lawsuits for the sum of $1 billion. The Paxil settlements will pay individual families approximately $1.2 million.
The remaining 100 Paxil lawsuits include three that are set for trial later this year in Philadelphia.
Paxil is a controversial anti-depressant drug that has been linked to birth defects in pregnant mothers who were taking the drug. Such birth defects include cardiac problems and pulmonary hypertension.
Latest posts by Jared Green (see all)
- New Hampshire Supreme Court Clarifies Law on Bystander Emotional Distress Claims - May 15, 2023
- Expert Testimony by Non-Party Medical Treaters in Medical Negligence Cases - March 2, 2023
- Colorectal Cancer Screening - November 6, 2020